These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1237 related items for PubMed ID: 20129072

  • 21. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China.
    Zong LJ, Zhang YZ, Yang XS, Jiang J, Cui BX, Qiao YB, Li L, Jiang K, Zhang WJ, Kong BH, Shen K.
    Asian Pac J Cancer Prev; 2015; 16(5):1907-12. PubMed ID: 25773843
    [Abstract] [Full Text] [Related]

  • 22. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 23. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T, Ivanus U, Jerman T, Takac I, Arko D.
    Radiol Oncol; 2021 Jan 06; 55(2):187-195. PubMed ID: 33764704
    [Abstract] [Full Text] [Related]

  • 24. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile.
    Ferreccio C, Barriga MI, Lagos M, Ibáñez C, Poggi H, González F, Terrazas S, Katki HA, Núñez F, Cartagena J, Van De Wyngard V, Viñales D, Brañes J.
    Int J Cancer; 2013 Feb 15; 132(4):916-23. PubMed ID: 22684726
    [Abstract] [Full Text] [Related]

  • 25. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E.
    Int J Gynecol Cancer; 2006 Feb 15; 16(2):591-8. PubMed ID: 16681731
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
    Şuteu O, Blaga ML, Nygård M, Leinonen MK, Nicula F, Păiş R, Coza D, Cadariu PA, Melnic A, Andreassen T, Hashim D, Weiderpass E.
    Eur J Cancer Prev; 2020 Mar 15; 29(2):141-148. PubMed ID: 31033568
    [Abstract] [Full Text] [Related]

  • 29. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 30. Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany.
    Petry KU, Luyten A, Scherbring S.
    Gynecol Oncol; 2013 Feb 05; 128(2):282-7. PubMed ID: 23088926
    [Abstract] [Full Text] [Related]

  • 31. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
    Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, Basu P.
    Int J Cancer; 2008 Jul 01; 123(1):153-60. PubMed ID: 18404671
    [Abstract] [Full Text] [Related]

  • 32. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.
    Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.
    J Clin Microbiol; 2015 Jan 01; 53(1):52-9. PubMed ID: 25339396
    [Abstract] [Full Text] [Related]

  • 33. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    Canfell K, Saville M, Caruana M, Gebski V, Darlington-Brown J, Brotherton J, Heley S, Castle PE.
    BMJ Open; 2018 Jan 26; 8(1):e016700. PubMed ID: 29374658
    [Abstract] [Full Text] [Related]

  • 34. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD, Dawlett M, Wang JP, Jack A, Gong Y, Staerkel G, Guo M.
    Arch Pathol Lab Med; 2015 Feb 26; 139(2):219-24. PubMed ID: 25611104
    [Abstract] [Full Text] [Related]

  • 35. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
    Aslan FG, Us T, Kaşifoğlu N, Özalp SS, Akgün Y, Öge T.
    Mikrobiyol Bul; 2016 Jan 26; 50(1):73-85. PubMed ID: 27058331
    [Abstract] [Full Text] [Related]

  • 36. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 Jan 26; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 37. Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.
    Fu Y, Li X, Li Y, Lu W, Xie X, Wang X.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0157021. PubMed ID: 35171029
    [Abstract] [Full Text] [Related]

  • 38. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE.
    Cancer Epidemiol; 2009 Dec 23; 33(6):446-50. PubMed ID: 19931499
    [Abstract] [Full Text] [Related]

  • 39. Validation of high-risk HPV tests for primary cervical screening.
    Meijer CJ, Berkhof H, Heideman DA, Hesselink AT, Snijders PJ.
    J Clin Virol; 2009 Nov 23; 46 Suppl 3():S1-4. PubMed ID: 20129067
    [Abstract] [Full Text] [Related]

  • 40. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
    Simms KT, Hall M, Smith MA, Lew JB, Hughes S, Yuill S, Hammond I, Saville M, Canfell K.
    PLoS One; 2017 Nov 23; 12(1):e0163509. PubMed ID: 28095411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.